Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public ...
The biotechnical research at the HudsonAlpha Institute for Biotechnology is once again in the national spotlight. The ...
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...
Central Ohio is a growing U.S. biotech hub because of decades of efforts, the head of a national trade group says.
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this ...
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...
Fermentation has evolved from a traditional preservation method into a cornerstone of modern food innovation, where the intersection of bioprocess ...
Zacks Investment Research on MSN
Should you invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results